Using the APP/PS1 double transgenic mouse model of AD and age- and sex-matched wild-type (WT) controls, our study aimed to identify potential sex-specific differences in synaptotoxicity and investigate the role of extrasynaptic GluN2B-containing NMDA receptors in AD pathogenesis. This evidence concerns the gene APP and Alzheimer disease.